論文（2013）

英文原著

1. Imam SZ, Trickler W, Kimura S, Binienda ZK, Paule MG, Slikker W, Li S, Clark RA, Ali SF: Neuroprotective efficacy of a new brain-penetrating c-Abl inhibitor in a murine Parkinsonʼs disease model. PLOS One 8, 65129, 2013.
2. Jin L, Tabe Y, Kojima K, Shikami M, Benito J, Ruvolo V, Wang RY, McQueen T, Ciurea SO, Miida T, Andreeff M, Konopleva M: PI3K inhibitor GDC-0941 enhances apoptotic effects of BH-3 mimetic ABT-737 in AML cells in the hypoxic bone marrow microenvironment. J Mol Med (Berl) 91(12), 1383-97, 2013.
3. Katagiri S, Tauchi T, Okabe S, Minami Y, Kimura S, Maekawa T, Naoe T, Ohyashiki K: Targeting the hedgehog signaling pathway in therapy-resistant BCR-ABL1 positive leukemia with ponatinib. Clin Cancer Res 19(6), 1422-1432, 2013.
4. Kato G, Takahashi K, Izuhara K, Komiya K, Kimura S and Hayashi S: Markers that can Reflect Asthmatic Activity before and after Reduction of Inhaled Corticosteroids: A Pilot Study. Biomark Insights 8, 97-105, 2013.
5. Kimura S, Ando T, Kojima K: Ever-advancing chronic myeloid leukemia treatment. Int J Clin Oncol, 2013.Azuma T, Tobinai K, Takeyama K, Shibata T, Hidaka M, Kurosawa M, Kasai M, Chou T, Fukushima N, Mu- kai K, Tsukasaki K, Shimoyama M: Japan Clinical Oncology Group-Lymphoma Study Group (JCOG-LSG) Phase II Study of Intensive Post-remission Chemotherapy and Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Japan Clinical Oncology Group Study, JCOG9402. Jpn J Clin Oncol 42, 394-404, 2012.
6. Kojima K, Kornblau SM, Ruvolo V, Dilip A, Duvvuri S, Davis RE, Zhang M, Wang Z, Coombes KR, Zhang N, Qiu YH, Burks JK, Kantarjian H, Shacham S, Kauffman M, Andreeff M: Prognostic impact and targeting of CRM1 in acute myeloid leukemia. Blood 121(20), 4166-74, 2013.
7. Kudo E, Taura M, Matsuda K, Shimamoto M, Kariya R, Goto H, Hattori S, Kimura S, Okada S: Inhibition of HIV-1 replication by a tricyclic coumarin GUT-70 in acutely and chronically infected cells. Bioorgan Med Chem Lett 23(3), 606-9, 2013.
8. Miyahara T, Mochinaga S, Kimura S, Aragane N, Yakabe T, Morita S, Okudaira K, Fujito H: Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients. Cancer Chemother Pharmacol 71(1), 175-82, 2013.
9. Nihon-Yanagi Y, Terai K, Murano T, Kawai T, Kimura S, Okazumi S: β-2 microglobulin is unsuitable as an internal reference for the analysis of gene expression in human colorectal cancer. Biomed Rep 1(2), 193-196, 2013.
10. Ogata M, Satou T, Kadota J, Saito N, Yoshida T, Okumura H, Ueki T, Nagafuji K, Kako S, Uoshima N, Tsudo M, Itamura H, Fukuda T: Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis ―1― after allogeneic hematopoietic cell transplantation: a multicenter, prospective study. Clin Infect Dis 57(5), 671-81, 2013.
11. Okabe S, Tauchi T, Tanaka Y, Kimura S, Maekawa T, Ohyashiki K: Activity of histone deacetylase inhibitors and an Aurora kinase inhibitor in BCR-ABL-expressing leukemia cells. Cancer Cell Int 13 (1), 32, 2013.
12. Shindo T, Kim TK, Benjamin CB, Wieder ED, Levy RB, Komanduri KV: MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-depenent manner (Plenary paper). Blood 121, 4617-4626, 2013.
13. Sueoka E, Sueoka-Aragane N, Sato A, Ide M, Nakamura H, Sotomaru Y, Taya C, Yonekawa H, Kitagawa T, Kubota Y, Kimura S, Nakamichi K, Tanimoto K: Development of lymphoproliferative diseases by hypoxia inducible factor-1 a is associated with prolonged lymphocyte survival. PLOS One 8 (4), e57833, 2013.
14. Takahashi H, Mizuta T, Oeda S, Isoda H, Nakashita S, Kawaguchi Y, Izumi N, Hirai M, Kurose K, Iwane S, Eguchi Y, Kimura S, Anzai K, Ozaki I: An automated rapid detection system using the quenching probe method for detecting interleukin 28B and inosine triphosphatase single nucleotide polymorphisms in chronic hepatitis C. J Viral Hepat 20(4), e124-126, 2013.
15. Yamada K, Takayama K, Kawakami S, Saruwatari K, Morinaga R, Harada T, Aragane N, Nagata S, Kishimoto J, Nakanishi Y, Ichinose Y: Phase II trial of erlotinib for Japanese patients with previously treated non-small-cell lung cancer harboring EGFR mutations: results of Lung Oncology Group in Kyushu (LOGiK 0803). Jpn J Clin Oncol 43, 629-35, 2013.
16. Yamakawa N, Ohto U, Akashi-Takamura S, Takahashi K, Saitoh S, Tanimura N, Suganami T, Ogawa Y, Shibata T, Shimizu T, Miyake K: Human TLR4 polymorphism D299 G/T399 I alters TLR 4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A. Int Immunol 25, 45-52, 2013.

英文症例報告　Letter to the editor

1. Uchihashi K, Nishijima-Matsunobu A, Matsuyama A, Yamasaki F, Tanabe T, Uemura T, Aragane N, Yakushiji M, Yamamoto M, Aoki S, Toda S: Phosphaturic mesenchymal tumor, nonphosphaturic variant, causing fatal pulmonary metastasis. Hum Pathol 44, 2614-8, 2013.
2. Yoshihara M, Itamura H, Fukushima N, Itoh M, Furukawa K, Nagatomo D, Kamachi K, Kitamura H, Shindo T, Kubota Y, Sueoka E, Morita S, Ichinohe T, Kimura S: Therapeutic management in cardiac lymphoma. Leuk Lymphoma. 2013, Sep 3. 2013.
3. Yakabe T, Kitahara K, Komiya K, Sueoka-Aragane N, Kimura S, Sugioka T, Noshiro H: Severe eosinophilic pneumonia presenting during gemcitabine adjuvant chemotherapy. World J Surg Oncol 11, 167. 2013.

英文総説

1. Vélez J, Hail N Jr, Konopleva M, Zeng Z, Kojima K, Samudio I, Andreeff M: Mitochondrial uncoupling and the reprograming of intermediary metabolism in leukemia cells. Front Oncol. 2013 Apr 2, 3, 67, 2013.

最終更新日：2015年4月16日